Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phoenix Creation Global is a biotechnology company specializing in regenerative medicine and advanced cellular therapies. The company focuses on the research, development, and distribution of stem cell-derived products, including exosomes, precursor cells, and organ-specific peptides. These products are primarily targeted at anti-aging, aesthetic medicine, and the management of chronic degenerative conditions. Headquartered in Malaysia, Phoenix Creation Global operates in close collaboration with the European Wellness Biomedical Group to integrate laboratory innovations into clinical practice. Their portfolio emphasizes cell-free therapies and biological regenerative solutions for a global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phoenix Creation Global.